3177.2000 26.30 (0.83%)
NSE Aug 01, 2025 15:31 PM
Volume: 204.2K
 

3177.20
0.83%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Number of FII/FPI investors decreased from 382 to 358 in Jun 2025 qtr
More from Dr. Lal Pathlabs Ltd.
Recommended